IS HEPARIN REPLACEMENT A RISK FOR POSTOPERATIVE BLEEDING DURING GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION?

IS HEPARIN REPLACEMENT A RISK FOR POSTOPERATIVE BLEEDING DURING GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION? - THE RISK OF HEPARIN REPLACEMENT DURING GASTRIC ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017223

Enrollment

300

Registered

2015-04-25

Start date

2015-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superficial gastric tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: expanded criteria for gastric ESD

Exclusion criteria

Exclusion criteria: patients who (1) had previous surgery, or (2) were lost to follow-up for 4 weeks after ESD.

Design outcomes

Primary

Measure	Time frame
postoperative bleeding rate	—

Countries

Japan

Contacts

Public ContactYohei Horikawa

Hiraka General Hospital Gastroenterology

horikawa_01@me.com0182-32-5121

Outcome results